Cresilon
Develops plant-based hemostatic gels to stop bleeding instantly.
biotechmedical-devices
Company facts
Series B-stage
- Founded
- 2010
- Employees
- 93
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $113M · 2025
Open positions
1 job
8 views 2 months ago
Manager/Principal Scientist Research & Development - Polymer Formulation
Open 62d On-siteNorth AmericaFull-timePrincipal 4 questions
United States
Brooklyn, New YorkCresilon ® is a Brooklyn-based biotechnology and medical device company that develops, manufactures, and markets hemostatic products, driven by a singular mission: to save lives . Powered by proprietary plant-based…
Business Development Go-to-Market Iso 13485 Personal Protective Equipment (PPE) Six Sigma